Jejunal Neoplasms are tumors or growths in the jejunum, a section of your small intestine. These growths can be benign (not cancerous) or malignant (cancerous). Doctors monitor these growths carefully.
Every report comes from a Lived member, sent anonymously.
Have you tried Gleevec (Imatinib) for Jejunal Tumors?
Jejunal tumors are growths that form in the jejunum, the middle section of the small intestine. The jejunum sits between the duodenum (the first part, just beyond the stomach) and the ileum (the last part, which joins the large intestine), and it does much of the work of absorbing nutrients from food. Some jejunal tumors are benign, meaning they do not spread elsewhere in the body, but many are cancers. Cancer of the small intestine is rare, making up only a few percent of cancers of the digestive tract. Jejunal tumor is an umbrella term rather than one disease. The main cancer types are adenocarcinoma, which starts in the gland cells lining the intestine; gastrointestinal stromal tumors (GISTs), which grow from the intestinal wall; neuroendocrine tumors, which start in hormone-producing cells; lymphoma, a cancer of immune cells; and sarcomas such as leiomyosarcoma, which start in muscle. The type shapes nearly every later decision, from how much bowel the surgeon removes to which further treatments can help. Symptoms are often vague and easy to blame on something else: cramping pain in the middle of the abdomen, unexplained weight loss, tiredness from anemia caused by slow, hidden bleeding, or blood in the stool. Some tumors are discovered only when they cause a complication, such as a blocked intestine or sudden bleeding.
Most jejunal tumors develop without an identifiable cause. Researchers have linked small intestine cancer to a few conditions that keep the intestinal lining inflamed or prone to abnormal growths. Crohn disease, a long-term inflammatory bowel disease that often involves the small intestine, and celiac disease, an immune reaction to gluten that damages the small intestine's lining, both raise risk. So does familial adenomatous polyposis (FAP), an inherited condition that causes many precancerous growths called polyps in the digestive tract. A diet high in fat has also been associated with higher risk. These are associations, not predictions. Most people with Crohn or celiac disease never develop small intestine cancer, and many people who do develop it have no known risk factor.
The jejunum is hard to examine directly. A standard upper endoscopy, in which a camera on a flexible tube is passed through the mouth, reaches only as far as the duodenum, and a colonoscopy examines the large intestine. The middle of the small intestine therefore needs other tests, which is one reason these tumors are often found late. CT (computed tomography) or MRI (magnetic resonance imaging) scans, sometimes with a contrast dye that is swallowed or injected, can show a mass, a narrowed segment or a blockage, and whether the tumor has spread to lymph nodes, the liver or the lining of the abdomen. Capsule endoscopy uses a pill-sized camera that a person swallows; it photographs the small intestine as it passes through. Balloon-assisted enteroscopy (often called double balloon enteroscopy) uses a long endoscope that works its way deep into the small intestine and can take a tissue sample, or biopsy. Blood tests look for anemia and check liver function. A biopsy examined under a microscope is what confirms whether a growth is cancer and which type it is. It is not always possible before surgery: the tumor may be out of reach, may grow outward from the bowel wall, or may need urgent surgery because of a blockage or bleeding. In one series, a biopsy taken during double balloon enteroscopy gave a diagnosis for about 6 in 10 tumor-like lesions; the rest were diagnosed only after surgery. In those cases the surgeon plans the operation from the scans, and the final diagnosis comes from the removed tissue. Staging, which describes how deeply the tumor has grown and whether it has spread, usually happens at the same time.
Surgery is the most common treatment and offers the main chance of cure. When the tumor can be removed, the surgeon takes out the affected section of the jejunum with a margin of normal tissue and joins the healthy ends back together. How the operation is done depends on the tumor type. For adenocarcinoma, the surgeon also removes nearby lymph nodes and the attached mesentery (the fan of tissue carrying the bowel's blood supply), because this cancer tends to spread there first. For a GIST, the priority is removing the tumor whole without rupturing it, and routine lymph node removal is usually unnecessary. For lymphoma, surgery plays a smaller role and is often prompted by a complication such as a blockage, bleeding or a hole in the bowel. When a tumor cannot be removed, surgery can still create a bypass that lets food get around a blockage, and radiation therapy can relieve symptoms and improve comfort. Treatment beyond surgery also depends on the type. For adenocarcinoma that has spread, chemotherapy typically combines two drug families, fluoropyrimidines and platinum drugs, in an approach borrowed from colon cancer. After surgery, chemotherapy may be discussed when the cancer had reached lymph nodes or grown through the bowel wall, to lower the chance of it returning. Because this cancer is so rare, much of this guidance rests on expert agreement and experience with colon cancer rather than large trials. GISTs that cannot be fully removed or have spread are commonly treated with imatinib (Gleevec), a targeted pill that blocks a growth signal these tumors rely on; it can shrink a tumor enough for surgery and is also used after surgery in some adults to reduce the chance of return. If imatinib stops working or causes side effects that are too difficult, other targeted drugs such as sunitinib are options. Neuroendocrine tumors and lymphoma have their own treatment approaches. Because these tumors are uncommon and varied, decisions are best made by a team that includes surgeons and cancer specialists. Clinical trials, including trials of immunotherapy, are an option worth asking about at any stage.
The outlook varies widely with tumor type and with whether the whole tumor can be removed. The best chance of cure comes when surgery removes all of the tumor, after which the main tasks are recovering from the operation and keeping up with follow-up. Adenocarcinoma is the more serious form: across all stages, fewer than 3 in 10 people are alive five years after diagnosis, largely because it is often found after it has already spread. Follow-up usually involves regular check-ups and repeat scans, first to see whether treatment is working and later to watch for the tumor coming back, which can happen in the small intestine or elsewhere in the body. Results from these visits guide whether treatment continues, changes or stops. For people whose cancer has spread, treatment is often ongoing and aims to control the disease and ease problems such as blockage or bleeding. Targeted therapy for GIST may be taken for as long as it keeps the tumor from growing and side effects remain manageable, so it becomes part of daily routine. Living with a rare cancer can also mean fewer familiar resources, so asking the care team about support services and specialist centers can help.
Arrange a medical visit for abdominal pain or cramping that keeps returning, weight loss you cannot explain, a lump you can feel in your abdomen, or persistent tiredness that could reflect anemia. If you are being treated or monitored for a jejunal tumor, contact your care team about new or worsening symptoms or difficult treatment side effects. Black, tarry stools, blood in the stool, or vomit that contains blood or looks like coffee grounds can mean bleeding in the digestive tract and needs same-day medical assessment. Severe cramping abdominal pain with repeated vomiting, a swollen belly, or being unable to pass gas or stool can signal a complete bowel blockage, which is an emergency: go to an emergency department. If bleeding comes with fainting, confusion, a racing heartbeat, or pale, cold, sweaty skin, which are signs of shock, call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Jejunal Tumors is like, what's helped you, or ask the community a question.